Stage IIIC Cutaneous Melanoma AJCC v7 Active Not Recruiting Phase 1 Trials for Hydroxychloroquine (DB01611)

IndicationStatusPhase
DBCOND0091049 (Stage IIIC Cutaneous Melanoma AJCC v7)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01480154Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney CancerTreatment